Table 1 Patient demographics
[All], N = 120 | Number | |
|---|---|---|
Age | 61 [54.7; 65.4] | 120 |
< 65 | 91 (75.8%) | |
> 65 | 29 (24.2%) | |
Sex | 120 | |
F | 22 (18.3%) | |
M | 98 (81.7%) | |
Disease | ||
ALD | 75 (62.5%) | |
HCV | 14 (11.7%) | |
HBV | 7 (5.8%) | |
Cryptogen | 12 (10%) | |
Other | 12 (10%) | |
AFP (ng/ml) | 8.00 [4.10; 70.0] | 105 |
Waiting_time (days) | 212 [72.5; 347] | 120 |
D (mm) | 33.2 (20.8) | 120 |
MELD | 11 [8; 15] | 97 |
MELD ≤ 15 | 71 (73.2%) | |
MELD = 15–30 | 17 (17.5%) | |
MELD > 30 | 9 (9.28%) | |
preTreat | 120 | |
No pre-treatment | 45 (37.5%) | |
Pre-treatment | 75 (62.5%) | |
N | 100 | |
N = 1 | 59 (59.0%) | |
N = 1–3 | 30 (30.0%) | |
N > 3 | 11 (11.0%) | |
Grade | 59 | |
1 | 23 (39.0%) | |
2 | 33 (55.9%) | |
3 | 3 (5.08%) | |
Asan | 120 | |
Exceeding | 35 (29.2%) | |
Fulfilling | 85 (70.8%) | |
AFP score | 105* | |
> 2 | 26 (24.8%) | |
≤ 2 | 79 (75.2%) | |
MC | 120 | |
Exceeding | 46 (38.3%) | |
Fulfilling | 74 (61.7%) | |
UTS | 120 | |
Exceeding | 34 (28.3%) | |
Fulfilling | 86 (71.7%) | |